Zenas BioPharma, Inc.
ZBIO
$7.93
$1.1516.96%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 516.93% | 434.91% | -- | -44.72% | -15.40% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 86.22% | 59.89% | -- | -- | 33.36% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 60.77% | -- | -- | -- | -- |
| Total Current Assets | 495.15% | 413.56% | -- | -- | -12.62% |
|
|
|||||
| Total Current Assets | 495.15% | 413.56% | -- | -- | -12.62% |
| Net Property, Plant & Equipment | 17.26% | -52.48% | -- | -- | -43.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 74.63% | 52.61% | -- | -- | 69.87% |
| Total Assets | 442.63% | 381.47% | -- | -- | -8.58% |
|
|
|||||
| Total Accounts Payable | 217.57% | 562.65% | -- | -- | -7.21% |
| Total Accrued Expenses | 130.29% | 124.69% | -- | -- | -12.51% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 41.19% | -34.13% | -- | -- | -22.24% |
| Total Finance Division Other Current Liabilities | -29.90% | -- | -- | -- | -- |
| Total Other Current Liabilities | -29.90% | -- | -- | -- | -- |
| Total Current Liabilities | 146.33% | 182.81% | -- | -- | -10.43% |
|
|
|||||
| Total Current Liabilities | 146.33% | 182.81% | -- | -- | -10.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -15.18% | -- | -- | -- | -68.35% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 31.26% | 22.42% | -- | -- | 63.62% |
|
|
|||||
| Common Stock & APIC | 14,962.54% | 19,962.63% | -- | -- | 349.23% |
| Retained Earnings | -68.14% | -62.66% | -- | -- | -19.21% |
| Treasury Stock & Other | 424.32% | -56.45% | -- | -- | 190.24% |
| Total Common Equity | 238.43% | 277.73% | -- | -31.31% | -17.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 4.17% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 4.17% | 4.17% |
|
|
|||||
| Total Common Equity | 238.43% | 277.73% | -- | -31.31% | -17.39% |
| Total Preferred Equity | -- | -- | -- | 4.17% | 4.17% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,182.41% | 651.11% | -- | -105.04% | -49.03% |
|
|
|||||
